Zobrazeno 1 - 10
of 107
pro vyhledávání: ''
Autor:
Céline Lepère, Karine Le Malicot, Juliette Palle, Lysiane Marthey, Simon Pernot, Olivier Dubreuil, Cedric Lecaille, Aziz Zaanan, Jean-Baptiste Bachet, Julien Taieb, Thomas Aparicio, David Tougeron
Publikováno v:
British Journal of Cancer
Background Triplet chemotherapy, with docetaxel-5FU-oxaliplatin (TEFOX), has yielded promising results in patients with advanced and operable gastric adenocarcinoma. This may prove useful in treating signet ring cell carcinoma (SRCC), which is known
Autor:
Pierre Laurent-Puig, Sylvain Poujol, Françoise Desseigne, S. Thezenas, Thibault Mazard, Evelyne Crapez, Emmanuelle Samalin, E. Francois, Antoine Adenis, T. Conroy, J.F. Seitz, Julien Taieb, M.P. Galais, Jaafar Bennouna, F. Boissière, Marc Ychou, Eric Assenat, O. Bouche, Frédéric Bibeau
Publikováno v:
British Journal of Cancer
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, 2014, 110, pp.1148--54. ⟨10.1038/bjc.2013.813⟩
Breast Cancer Research and Treatment, Springer Verlag, 2014, 110, pp.1148--54. ⟨10.1038/bjc.2013.813⟩
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, 2014, 110, pp.1148--54. ⟨10.1038/bjc.2013.813⟩
Breast Cancer Research and Treatment, Springer Verlag, 2014, 110, pp.1148--54. ⟨10.1038/bjc.2013.813⟩
IMPACT: 5.922; International audience; BACKGROUND: This trial evaluated the feasibility and efficacy of combined sorafenib and irinotecan (NEXIRI) as second- or later-line treatment of patients with KRAS-mutated metastatic colorectal cancer (mCRC), w
Autor:
Claudio Doglioni, Silvia Zanon, Paolo Passoni, Roberto Nicoletti, Gianpaolo Balzano, Michele Reni, Paolo Giorgio Arcidiacono, Clara Fugazza, Luca Gianni, Domenica Ceraulo, Gino Pepe, Massimo Falconi
Publikováno v:
British Journal of Cancer
Background: Nab-paclitaxel-gemcitabine combination significantly improved overall survival over gemcitabine in metastatic pancreatic adenocarcinoma. A phase 1b trial was performed (ClinicalTrials.gov number, NCT01730222) to determine the recommended
Autor:
S. H. Choi, Byung Soh Min, Jae Hee Cheon, Sang Joon Shin, Hoguen Kim, Hyuk Hur, Nam Kyu Kim, Kang Young Lee
Publikováno v:
British Journal of Cancer
Background: This study aims to evaluate the effectiveness of adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided neoadjuvant chemotherapy for increasing resectability in patients with unresectable colorectal liver metastasis. Pa
Autor:
S. Brugnara, Vanna Chiarion-Sileni, G.L. De Salvo, Jacopo Pigozzo, Michele Guida, Laura Ridolfi, P. Del Bianco, Antonella Romanini, Ruggero Ridolfi, G Colucci
Publikováno v:
British Journal of Cancer
Background: This study compared the central nervous system (CNS) metastasis incidence between a temozolomide- and a dacarbazine-based regimen in untreated stage IV melanoma patients. Methods: A total of 150 patients were randomly assigned to receive
Autor:
P García-Alfonso, Y Jerez-Gilarranz, S Alvarez-Suarez, P Khosravi, Miguel Martín, M Riesco-Martinez, A J Muñoz-Martin
Publikováno v:
British Journal of Cancer
Background: Combination of capecitabine and irinotecan (XELIRI regimen) is an active and well tolerated treatment for metastatic colorectal cancer (mCRC). The aim of this study was to evaluate the efficacy and safety of this regimen in combination wi
Autor:
Yoshihiro Nambu, A Funakoshi, Masaru Miyazaki, Kohei Nakachi, Satoshi Kondo, Yuji Nimura, Shinichi Ohkawa, Takuji Okusaka, Akira Fukutomi, Junji Furuse, Masato Nagino, S Nagaoka, Norifumi Mizuno, Minori Koshiji, J Funai
Publikováno v:
British Journal of Cancer
Background: A British randomised study of gemcitabine plus cisplatin (GC) combination showed promising results in biliary tract cancer (BTC) patients. In our study, we evaluated the efficacy and safety of this combination compared with gemcitabine al
Autor:
Tim Meyer, A Mayer, Federica Grillo, Christos Toumpanakis, Nicholas C. Turner, Richard H. J. Begent, Debashis Sarker, A. Papadopoulou, Daniel Hochhauser, Jimmy D. Bell, Amy A Kirkwood, Sandra J. Strauss, Irfan Kayani, Martyn Caplin, A. Hackshaw, Roopinder Gillmore
Publikováno v:
British Journal of Cancer
BACKGROUND: The role of chemotherapy for neuroendocrine tumours remains controversial and there is no standard regimen.METHODS: We report the outcome for a consecutive series of chemonaive patients with metastatic or locally advanced neuroendocrine t
Autor:
Atsushi Ohtsu, Yasuhide Yamada, Yasutsuna Sasaki, Kuniaki Shirao, Yusuke Tanigawara, Taroh Satoh, Yasuhiro Shimada, T. Miya, Makoto Tahara
Publikováno v:
British Journal of Cancer
Two phase II studies of S-1 monotherapy have shown promising response rates (RR) of 35-40% with good tolerability in patients with untreated metastatic colorectal cancer. To investigate the usefulness of S-1 plus oxaliplatin (SOX) as an alternative t
Autor:
Nagahiro Saijo, Kazuhiko Nakagawa, Tomohide Tamura, Hiroshi Nokihara, Ikuo Sekine, Hiroshi Isobe, Yutaka Nishiwaki, K Takeda, K Mori, Kaoru Matsui
Publikováno v:
British Journal of Cancer
Patients with previously untreated extensive-disease small-cell lung cancer were treated with irinotecan 60 mg m(-2) on days 1 and 8 and cisplatin 60 mg m(-2) on day 1 with (n=55) or without (n=54) etoposide 50 mg m(-2) on days 1-3 with granulocyte c